The eighth batch of centralized procurement refers to China's government-organized centralized procurement plan for medicines, and at the end of 2018, the Circular of the National Medical Security Bureau, the Ministry of Finance, and the National Healthcare Commission on the Issuance of the Work Plan for State-Organized Centralized Procurement and Use of Pharmaceuticals (2018-2020) clarified the direction of and timetable for the implementation of this plan. The purpose of the eighth batch of centralized procurement is to reduce drug prices and ease drug shortages, while promoting competition in the drug market and providing people with better quality healthcare services. The plan announced the Centralized Procurement Drug Catalogue (2019 Edition) in 2019,*** incorporating 25 medicines for the treatment of common and rare diseases, covering a wide range of areas such as oncology, cardiovascular and respiratory. The bidding for the eighth batch of centralized procurement started on January 11, 2022, with a deadline of January 20 and results announced on April 26th. The tender*** was won by 45 companies, including well-known domestic and international pharmaceutical companies. The centralized procurement will be executed from 2022 to 2023.
What is the impact of the implementation of centralized purchasing on the medical industry and patients? The implementation of centralized purchasing can reduce drug prices and promote market competition, thus reducing the burden of patients' medication and improving people's medical experience. In addition, centralized purchasing can also promote the healthy development of China's pharmaceutical industry and encourage enterprises to carry out technological innovation and quality improvement.
The eighth batch of centralized purchasing is an important measure launched by China's government in order to reduce drug prices and alleviate drug shortages. The implementation of the program can promote market competition and enterprise innovation, while providing people with better quality medical services. We look forward to the further advancement of centralized purchasing in the future, which will provide more protection for the development of social economy and the well-being of the people.
Legal basis:
Article 28 of the Law of the People's Republic of China on Bidding and Tendering The bidder shall deliver the bidding documents to the place of bidding before the deadline for submitting the bidding documents as required by the bidding documents. Upon receipt of the bidding documents, the bidder shall sign for their preservation and shall not open them. Where there are fewer than three bidders, the bidder shall re-tender in accordance with this Law. Bidding documents delivered after the deadline for submission of bidding documents, the bidder shall refuse to accept.